Therapeutic drug monitoring: Toward tailored dosing of adalimumab in rheumatoid arthritis.
Latest Information Update: 03 Oct 2017
At a glance
- Drugs Adalimumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 22 Sep 2017 Primary endpoint (Disease activity score ) has been met as per results published in the Annals of the Rheumatic Diseases.
- 22 Sep 2017 Status changed to discontinued due to change in the institution preference policy for biological disease-modifying anti-rheumatic drugs disease-modifying anti-rheumatic drugs decreasing the number of eligible patients,as per results published in the Annals of the Rheumatic Diseases.
- 22 Sep 2017 Results published in the Annals of the Rheumatic Diseases